Public Policy Forum: Laura Adams – Sr. Advisor of Artificial Intelligence at the National Academy of Medicine (NAM)

“Governing AI in Healthcare: the Hope, the Hype, the Promise and the Peril.”

Laura Adams, Senior Advisor at the National Academy of Medicine (NAM), provides strategic leadership for the Science and Technology portfolio and leads the NAM’s Artificial Intelligence Code of Conduct national initiative. Her expertise is in AI, digital health, and human-centered care. Laura is a member of the international AI Expert Panel for the Organization of Economic Co-operation and Development (OECD); the Bipartisan Policy Center’s Health Care AI Advisory Panel, and the Consumer Technology Association’s Health AI Planning Council.

Laura chairs the Global Opportunities Group for the AI Regulatory Science and Innovation Network in the UK, and she is a strategic advisor for Inflammatix, a Burlingame, CA-based biotech company specializing in host immune response diagnostics. She chaired the Institute of Medicine’s (IOM) Digital Infrastructure for the Learning Healthcare System initiative.She is recognized as a strategic leader of large scale multisectoral initiatives with a deep experience in and understanding of the complex U.S. health care industry, including how the components function and interact.

 Laura was among the first to bring the science of healthcare quality improvement to the Middle East, in conjunction with Donald Berwick, MD and the Harvard Institute for Social and Economic Policy in the Middle East. She served as Institute for Healthcare Improvement (IHI) faculty at the inaugural IHI Middle East Forum on Quality Improvement in Healthcare in Doha, Qatar.